+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Streck Inc - Product Pipeline Analysis, 2018 Update

  • PDF Icon

    Company Profile

  • 24 Pages
  • December 2018
  • GlobalData
  • ID: 4708847
Summary

Streck Inc (Streck) is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentation-rate, chemistry, whole blood, whole blood glucose and hemoglobin, instruments and consumables, antibiotic resistance kits, reagents and thermometers. It also provides laboratory products, blood collection tubes, multi-parameter assayed hematology controls; linearity and calibration verification materials; molecular instruments and consumables, kits and reagents, and a real-time PCR system; laboratory thermometers; and blood collection tubes. It conducts research and development programs. The company market its products through a network of distributors. Streck is headquartered in Omaha, Nebraska, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Streck Inc

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Streck Inc Company Overview
Streck Inc Company Snapshot
Streck Inc Pipeline Products and Ongoing Clinical Trials Overview
Streck Inc – Pipeline Analysis Overview
Streck Inc - Key Facts
Streck Inc - Major Products and Services
Streck Inc Pipeline Products by Development Stage
Streck Inc Pipeline Products Overview
CD-Chex CD103 Plus
CD-Chex CD103 Plus Product Overview
CD-Chex CD117 Plus
CD-Chex CD117 Plus Product Overview
CD-Chex Select
CD-Chex Select Product Overview
CD-Chex TdT Plus
CD-Chex TdT Plus Product Overview
LBC-Chex
LBC-Chex Product Overview
Streck Inc - Key CompetitorsStreck Inc - Key Employees
Streck Inc - Locations And Subsidiaries
Head Office
Recent Developments
Mar 27, 2018: Streck granted another patent directed toward direct-draw blood collection tubes for blood stabilization
Feb 23, 2018: Streck files suit against Cenata for infringement of its European Patent
May 10, 2017: Streck signs distribution agreement with Genomax Technologies
Apr 10, 2017: Streck signs distribution agreement with RUWAG Diagnostics
Feb 01, 2017: Streck signs distribution agreement with HiSS Diagnostics
Oct 25, 2016: Streck announces Canadian patent for blood collection tubes
Oct 13, 2016: Eric Riley joins Streck as Human Resources Director
Jul 26, 2016: Streck signs exclusive distribution agreement with Diesse
Jul 14, 2016: Streck and Biodesix sign exclusive supply agreement for DNA and RNA tubes
Jan 23, 2012: Streck Adds CD38 To Flow Cytometry Controls
Appendix
Methodology
About
Contact Us
Disclaimer
List of Tables
Streck Inc Pipeline Products and Ongoing Clinical Trials Overview
Streck Inc Pipeline Products by Equipment Type
Streck Inc, Key Facts
Streck Inc, Major Products and Services
Streck Inc Number of Pipeline Products by Development Stage
Streck Inc Pipeline Products Summary by Development Stage
CD-Chex CD103 Plus - Product Status
CD-Chex CD103 Plus - Product Description
CD-Chex CD117 Plus - Product Status
CD-Chex CD117 Plus - Product Description
CD-Chex Select - Product Status
CD-Chex Select - Product Description
CD-Chex TdT Plus - Product Status
CD-Chex TdT Plus - Product Description
LBC-Chex - Product Status
LBC-Chex - Product Description
Streck Inc, Key Employees
Glossary
List of Figures
Streck Inc Pipeline Products by Equipment Type
Streck Inc Pipeline Products by Development Stage 8

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ALPCO Diagnostics

  • BellBrook Labs LLC

  • Diazyme Laboratories Inc